Cited by 365Pancreatic function and diabetesBariatric Surgery and OutcomesDiabetes Management and Research

Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.

Open access
Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M. +4 more·2005·Diabetologia

Abstract

Aims/hypothesis Postprandial hypoglycaemia following gastric bypass for obesity is considered a late manifestation of the dumping syndrome and can usually be managed with dietary modification. We investigated three patients with severe postprandial hypoglycaemia and hyperinsulinaemia unresponsive to diet, octreotide and diazoxide with the aim of elucidating the pathological mechanisms involved.Methods Glucose, insulin, and C-peptide were measured in the fasting and postprandial state, and insulin secretion was assessed following selective intra-arterial calcium injection. Pancreas histopathology was assessed in all three patients.Results All three patients had evidence of severe postprandial hyperinsulinaemia and hypoglycaemia. In one patient, reversal of gastric bypass was ineffective in reversing hypoglycaemia. All three patients ultimately required partial pancreatectomy for control of neuroglycopenia; pancreas pathology of all patients revealed diffuse islet hyperplasia and expansion of beta cell mass.Conclusions/interpretation These findings suggest that gastric bypass-induced weight loss may unmask an underlying beta cell defect or contribute to pathological islet hyperplasia, perhaps via glucagon-like peptide 1-mediated pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-005-1933-x

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anecdotal evidence suggests that off-label diazoxide administered at doses ranging from 100 mg to 150 mg three times daily may be effective in the treatment of late dumping symptoms, but no effect on early symptoms is expected because of its mode of action.

    “Anecdotal evidence suggests that off-label diazoxide administered at doses ranging from 100 mg to 150 mg three times daily may be effective in the treatment of late dumping symptoms, but no effect on early symptoms is expected because of its mode of action (103).”

    From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [103]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Some persons who have undergone Roux-en-Y gastric bypass for obesity have endogenous hyperinsulinemic hypoglycemia most often due to pancreatic islet nesidioblastosis, but occasionally due to an insulinoma.

    “Some persons who have undergone Roux-en-Y gastric bypass for obesity have endogenous hyperinsulinemic hypoglycemia most often due to pancreatic islet nesidioblastosis, but occasionally due to an insulinoma (48 -50).”

    From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [49]

    The Introduction and Conclusions describe three post-bypass patients with hyperinsulinaemic hypoglycaemia and islet hyperplasia; Patient 1’s pathology specifically showed nesidioblastosis. The Conclusions also report an insulinoma in another post-bypass patient. The paper does not establish that nesidioblastosis is the most common cause of endogenous hyperinsulinaemic hypoglycaemia after bypass. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Various surgical re-interventions have been used, including gastric tube placement, gastric bypass reversal with or without concomitant sleeve resection and gastric pouch restriction.

    “Various surgical re-interventions have been used, including gastric tube placement, gastric bypass reversal with or without concomitant sleeve resection and gastric pouch restriction (Table 5) (66,103,105-123).”

    From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [103]

    The Patient 1 section reports that a gastric bypass was taken down, supporting bypass reversal as one surgical re-intervention. The passages do not report gastric tube placement, reversal with sleeve resection, or gastric pouch restriction; Patient 2 says reversal and gastrectomy were considered but not possible. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Pancreatic resection, the most commonly reported procedure, was performed in approximately 67% of patients.

    “Pancreatic resection, the most commonly reported procedure, was performed in approximately 67% of patients (66,103,105,107,114,116-123).”

    From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [103]

    The Patient 1–3 sections report pancreatic resections in all three patients described. The paper does not report that resection was the most commonly performed procedure or that it was performed in approximately 67% of patients across the cases cited. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Approximately 24% of patients who underwent surgical re-intervention because of refractory severe post-Roux-en-Y gastric bypass hypoglycemia received a gastric bypass reversal and approximately 9% had gastric pouch restriction.

    “As shown in Table 5, approximately 24% of patients who underwent surgical re-intervention because of refractory severe post-Roux-en-Y gastric bypass hypoglycemia received a gastric bypass reversal (66,103,106-113) and approximately 9% had gastric pouch restriction (66,114,115).”

    From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [103]

    Patient 1 reports a gastric bypass take-down after severe hypoglycaemia, so the paper supports an example of reversal. It does not report gastric pouch restriction or the approximately 24% and 9% rates; its Introduction describes a three-patient case series, not the pooled group underlying those percentages. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 13 · Cited by 365

Authors
Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., Bonner-Weir, S., & Goldfine, A. B.
Affiliations
  • Joslin Diabetes Center (US)
  • Brigham and Women's Hospital (US)
  • Beth Israel Deaconess Medical Center (US)
  • University of Copenhagen (DK)
Corresponding author
Patti, M. E.
Venue
Diabetologia
Published
2005-09-30
Volume
48
Issue
11
Pages
2236-2240
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2003725355
Cited by
365
References
13
Citations by year
2026: 7 · 2025: 5 · 2024: 9 · 2023: 8 · 2022: 14 · 2021: 17 · 2020: 11 · 2019: 13 · 2018: 12 · 2017: 16 · 2016: 31 · 2015: 23 · 2014: 23 · 2013: 18 · 2012: 18
FWCI
18.14
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • National Institutes of Health (RR 01032)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K23DK002795, DK 44523, DK-062948, DK02795, R01DK044523, R01DK062948)
  • National Center for Research Resources (M01-RR-01032, M01RR001032)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
postprandial hypoglycemia, gastric bypass, bariatric surgery, partial pancreatectomy, hyperinsulinemia, pancreatic islet hyperplasia, dumping syndrome, obesity, glucagon-like peptide-1, neuroglycopenia
MeSH terms
Insulin Secretion, Adult, Aged, Diazoxide, Diet Therapy, Dumping Syndrome, Female, Humans, Hyperplasia, Hypoglycemia, Insulin, Islets of Langerhans, Male, Middle Aged, Pancreas, Pancreatectomy, Octreotide, Gastric Bypass

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review